Expression of glutamic acid decarboxylase (GAD) in the α, β and δ cells of normal and diabetic pancreas: implications for the pathogenesis of type I diabetes

• DOI: 10.1111/j.1365-2249.1993.tb03410.x
• Publication Date: 2010-07-26T17:06:00Z
• Authors: M VIVES-PI; N SOMOZA; F VARGAS; P ARMENGOL; Y SARRI; J Y WU; R PUJOL-BORRELL
• Keywords: Adult; Male; 0301 basic medicine; Cytoplasm; Glutamate Decarboxylase; Cell Membrane; Fluorescent Antibody Technique; Autoantigens; 3. Good health; Islets of Langerhans; 03 medical and health sciences; Diabetes Mellitus, Type 1; Humans; Female; Pancreas; Cells, Cultured

SUMMARY One of the paradoxes of insulin-dependent diabetes mellitus is that the destruction of the pancreatic islets’ endocrine cells is restricted to the insulin-producing β cells, whereas the main autoantibodies, islet cell antibodies (ICA), are directed against all endocrine islet cells. GAD has recently been proposed as the main target of the humoral and cellular autoimmune attack to the islets, and since in rat pancreas this enzyme was expressed only in the β cells, this provided an explanation for the cell specificity of the destructive process. The finding of GAD-positive cells in the islets of two diabetic patients, one of whom had completely lost the β cells, led us to study in detail thedistribution of GAD in normal human islet ceils using a panel of GAD aniiscra and the double indirect immunofluorescence technique on cryostat sections, monolayer cultures and cytosmears. The results showed that GAD is present not only in the cytoplasm of β cells but also in 69% of the α and 27% of the δ cells. GAD was not present, however, on the surface of the islet cells. These results suggest that the cellular distribution of GADcan not by itself explain the selectivity of β cell destruction in insulin-dependent diabetes mellitus.